Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2025-12-25 @ 1:51 PM
NCT ID: NCT04188392
Description: Assessed with staff-administered questionnaire at all in-person and telephone visits following enrollment
Frequency Threshold: 0
Time Frame: 10 weeks
Study: NCT04188392
Study Brief: Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Open-label Treatment pimavanserin 34mg at bedtime for 6 weeks Pimavanserin: pimavanserin tablet 0 None 0 6 6 6 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
skin irritation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (12.0) View
skin irritation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (12.0) View
sleepiness SYSTEMATIC_ASSESSMENT General disorders MedDRA (12.0) View
dry mouth SYSTEMATIC_ASSESSMENT General disorders MedDRA (12.0) View
headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (12.0) View
arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (12.0) View
diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (12.0) View
weight gain SYSTEMATIC_ASSESSMENT General disorders MedDRA (12.0) View